North Star Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $632 | Hold |
13
| – | – | ﹤0.01% | 1149 |
|
|
2025
Q1 | $442 | Hold |
13
| – | – | ﹤0.01% | 1149 |
|
|
2024
Q4 | $512 | Hold |
13
| – | – | ﹤0.01% | 1168 |
|
|
2024
Q3 | $611 | Hold |
13
| – | – | ﹤0.01% | 1131 |
|
|
2024
Q2 | $702 | Hold |
13
| – | – | ﹤0.01% | 1107 |
|
|
2024
Q1 | $886 | Hold |
13
| – | – | ﹤0.01% | 1165 |
|
|
2023
Q4 | $814 | Hold |
13
| – | – | ﹤0.01% | 1121 |
|
|
2023
Q3 | $590 | Hold |
13
| – | – | ﹤0.01% | 1189 |
|
|
2023
Q2 | $730 | Hold |
13
| – | – | ﹤0.01% | 1190 |
|
|
2023
Q1 | $588 | Hold |
13
| – | – | ﹤0.01% | 1224 |
|
|
2022
Q4 | $528 | Hold |
13
| – | – | ﹤0.01% | 1234 |
|
|
2022
Q3 | $1K | Hold |
13
| – | – | ﹤0.01% | 1069 |
|
|
2022
Q2 | $1K | Hold |
13
| – | – | ﹤0.01% | 1076 |
|
|
2022
Q1 | $1K | Hold |
13
| – | – | ﹤0.01% | 1090 |
|
|
2021
Q4 | $1K | Sell |
13
-600
| -98% | -$46.2K | ﹤0.01% | 1119 |
|
|
2021
Q3 | $69K | Hold |
613
| – | – | 0.01% | 531 |
|
|
2021
Q2 | $99K | Buy |
613
+300
| +96% | +$48.5K | 0.01% | 482 |
|
|
2021
Q1 | $38K | Buy |
313
+300
| +2,308% | +$36.4K | ﹤0.01% | 600 |
|
|
2020
Q4 | $2K | Buy |
+13
| New | +$2K | ﹤0.01% | 952 |
|